Breckenridge Signs Agreement with Helm AG

Jan. 7 / Breckenridge announced today that it has entered into an agreement with Helm AG to develop and manufacture a generic tablet ANDA product. Breckenridge expects to file an ANDA with theFDA in January 2008. Upon approval by the FDA, Helm AG will supply andBreckenridge will market and distribute the product on an exclusive basis. Under terms of the agreement, Breckenridge will submit an ANDA to the U.S.Food and Drug Administration (FDA) for the product which as been developed byHelm AG. The product currently shows U.S. sales of approximately $800million.